» Authors » Eric J Moore

Eric J Moore

Explore the profile of Eric J Moore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 218
Citations 1892
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bartemes K, Moore R, Novotny B, Pavelko K, Sherman W, Rivera M, et al.
Clin Cancer Res . 2025 Feb; PMID: 39964349
Background: Tumor-infiltrating lymphocytes (TILs) are associated with decreased risk of recurrence in human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV(+)OPSCC). The composition and spatial distribution of TILs and tumor-infiltrating immune cells...
2.
Calcano G, Rourk K, Routman D, OByrne J, Chintakuntlawar A, Garcia J, et al.
Otolaryngol Head Neck Surg . 2025 Jan; PMID: 39764676
Objective: Margin distance is a significant prognosticator in oral cavity cancer but its role in HPV-related oropharyngeal squamous cell carcinoma [HPV(+)OPSCC] remains unclear. Here, we investigate the impact of margin...
3.
Sankar G, Daher G, Peraza L, Moore E, Price D, Tasche K, et al.
Oral Oncol . 2024 Dec; 161():107147. PMID: 39708714
No abstract available.
4.
Calcano G, Rourk K, Glasgow A, Habermann E, Henson J, Price D, et al.
Otolaryngol Head Neck Surg . 2024 Dec; 172(3):913-921. PMID: 39675031
Objective: The extent of parotidectomy for benign tumors has de-escalated in the United States. We aim to define modern benchmarks for operative time and hospital length of stay (LOS) in...
5.
Nakkireddy S, Jang I, Kim M, Yin L, Rivera M, Garcia J, et al.
Commun Med (Lond) . 2024 Oct; 4(1):190. PMID: 39363031
Background: Deep learning techniques excel at identifying tumor-infiltrating lymphocytes (TILs) and immune phenotypes in hematoxylin and eosin (H&E)-stained slides. However, their ability to elucidate detailed functional characteristics of diverse cellular...
6.
Moore E, Rice M, Roy G, Zhang W, Marelli M
Xenobiotica . 2024 Sep; 54(8):469-491. PMID: 39329289
Antibody drug conjugates are an exciting therapeutic modality that combines the targeting specificity of antibodies with potent cytotoxins to selectively kill cancer cells. The targeting component improves efficacy and protects...
7.
Graves J, Daher G, Bauman M, Moore E, Tasche K, Price D, et al.
Oral Oncol . 2024 Sep; 159:107017. PMID: 39265195
No abstract available.
8.
Armstrong M, Burkett B, OByrne T, Gottlich H, Yin L, Tasche K, et al.
JAMA Otolaryngol Head Neck Surg . 2024 Aug; 150(12):1078-1086. PMID: 39207815
Importance: Asymmetric oropharynx uptake on positron emission tomography (PET)/computed tomography (CT) is a common incidental finding and often prompts otolaryngology referral to rule out malignancy; however, the true risk of...
9.
Graves J, Bukowski E, OByrne T, Yin L, Tasche K, Van Abel K, et al.
Am J Otolaryngol . 2024 Aug; 45(6):104446. PMID: 39096567
Objectives: Acinic cell carcinoma (ACC) most frequently arises in the parotid gland. Treatment consists of surgical resection and sometimes adjuvant therapy. ACC is most often a low-grade malignancy with good...
10.
Yang S, Morton Z, Colcord M, Jackson R, Moore E, Thuener J, et al.
Laryngoscope . 2024 Jul; 134(12):4923-4928. PMID: 38984420
Introduction: Cervical spine defects result in spinal instability, putting the spinal cord and vertebral arteries at risk of damage and possibly devastating neurological injuries. The fibula free flap can span...